Development and validation of patient-community pharmacist encounter toolkit regarding substance misuse: Delphi procedure
Fatani S, Bakke D, Halpape K, D’Eon M, El-Aneed A., J Am Pharm Assoc. 2022
Topic
Prescription Monitoring
Publications
Prescription drug misuse among adults in Canada: a scoping review
Abayateye, F., Fornssler, B., Feng, C., D’Arcy, C., Alphonsus, K., Journal of Substance Use. 2022
Interventions to Reduce Opioid Use in Youth At-Risk and in Treatment for Substance Use Disorders: A Scoping Review
Nairn SA, Audet M, Stewart SH, Hawke LD, Isaacs JY, Henderson J, Saah R, Knight R, Fast D, Khan F, Lam A, Conrod P., Canadian Journal of Psychiatry, 2022
“COVID just kind of opened a can of whoop-ass”: The rapid growth of safer supply prescribing during the pandemic documented through an environmental scan of addiction and harm reduction services in Canada
Glegg S, McCrae K, Kolla G, Touesnard N, Turnbull J, Brothers TD, Brar R, Sutherland C, Le Foll B, Sereda A, Goyer MÈ, Rai N, Bernstein S, Fairbairn N., Canada. Int J Drug Policy. 2022
Office-based Methadone Prescribing for Opioid Use Disorder: The Canadian Model
Kleinman RA, Brothers TD, Danilewitz M, Bahji A., J Addict Med. 2022
Supporting Self-isolation for COVID-19 With “Risk Mitigation” Prescribing and Housing Supports for People Who Use Drugs: A Case Report
Hong RH, Brar R, Fairbairn N., J Addict Med. 2022
Buprenorphine/naloxone and methadone effectiveness for reducing craving in individuals with prescription opioid use disorder: Exploratory results from an open-label, pragmatic randomized controlled trial
McAnulty C, Bastien G, Eugenia Socias M, Bruneau J, Le Foll B, Lim R, Brissette S, Ledjiar O, Marsan S, Talbot A, Jutras-Aswad D; OPTIMA Research Group within the Canadian Research Initiative in Substance Misuse., Drug Alcohol Depend. 2022
Impact of fentanyl use on initiation and discontinuation of methadone and buprenorphine/naloxone among people with prescription-type opioid use disorder: secondary analysis of a Canadian treatment trial
Socias ME, Wood E, Le Foll B, Lim R, Choi JC, Mok WY, Bruneau J, Rehm J, Wild TC, Bozinoff N, Hassan A, Jutras-Aswad D; OPTIMA Research Group within the Canadian Research Initiative in Substance Misuse.,
Development and pilot evaluation of an educational session to support sparing opioid prescriptions to opioid naïve patients in a Canadian primary care setting
Narayan S, Rizzardo S, Hamilton MA, Cooper I, Maclure M, McCracken RK, Klimas J., Fam Pract. 2022
Discontinuation and tapering of prescribed opioids and risk of overdose among people on long-term opioid therapy for pain with and without opioid use disorder in British Columbia, Canada: A retrospective cohort study
Kennedy MC, Crabtree A, Nolan S, Mok WY, Cui Z, Chong M, Slaunwhite A, Ti L., PLoS Med. 2022
Risk mitigation guidance and safer supply prescribing among young people who use drugs in the context of COVID-19 and overdose emergencies
Giang K, Charlesworth R, Thulien M, Mulholland A, Barker B, Brar R, Pauly B, Fast D., Int J Drug Policy. 2023
Effects of Buprenorphine/Naloxone and Methadone on Depressive Symptoms in People with Prescription Opioid Use Disorder: A Pragmatic Randomised Controlled Trial
Bastien G, McAnulty C, Ledjiar O, Socias ME, Le Foll B, Lim R, Hassan AN, Brissette S, Marsan S, Talbot A, Jutras-Aswad D; OPTIMA Research Group within the Canadian Research Initiative in Substance Misuse., Can J Psychiatry. 2023
RE: Incorporating prescription psychostimulants into the continuum of care for people with stimulant use disorder in Canada
Elefante J, Nolan S, Bach P, CMAJ, 2023
Evidence base to support using prescribed psychostimulants to treat psychostimulant use disorder is limited
Bahji A, Danilewitz M, George TP, Dhaliwal A, Crockford DN., CMAJ. 2023
“I thought it was for guys that did needles”: Medication perceptions and lay expertise among medical research participants
Jaffe K, Richardson L., Subst Use Addict Treat. 2023
Evaluation of audit and feedback to family physicians on prescribing of opioid analgesics to opioid-naïve patients: A pragmatic randomized delay trial
McCracken RK, Narayan S, Maclure M, Cooper I, Cui Z, Cullen W, Dormuth C, Hamilton MA, Nolan S, Singer J, Socías ME, Wong S, Klimas J., Contemp Clin Trials. 2023
Trajectories of opioid consumption as predictors of patient-reported outcomes among individuals attending multidisciplinary pain treatment clinics
Angarita-Fonseca A., Lacasse A., Choinière M., Kaboré J.-L., Sylvestre M.-P., Dinkou G.D.T., Bruneau J., Martel M.O., Hovey R., Motulsky A., Rahme E., Pagé M.G., Pharmacoepidemiology and Drug Safety, 2024
Denial of prescription pain medication among people who use drugs in Vancouver, Canada
Piret EM, Milloy MJ, Voon P, Choi J, DeBeck K, Hayashi K, Kerr T., Harm Reduct J. 2024
Barriers and facilitators for family physicians prescribing opioid agonist therapy in Saskatchewan
Nguyen T, Bareham J, Halpape K., Canadian Family Physician, 2024
A Prospective Cohort Study of Acute Pain and In-Hospital Opioid Consumption After Cardiac Surgery: Associations With Psychological and Medical Factors and Chronic Postsurgical Pain
Pagé M.G., Ganty P., Wong D., Rao V., Khan J., Ladha K., Hanlon J., Miles S., Katznelson R., Wijeysundera D., Katz J., Clarke H., Anesthesia & Analgesia, 2024
Evaluation of an infographic: prescription drug misuse among older adults in Saskatchewan
Alphonsus, K., Ahmed, M. D., Scheck, H., & Fornssler, B., Journal of Substance Use, 2024
What Psychiatrists Should Know About Prescribed Safer Opioid Supply
Bahji A, Danilewitz M, Sachdev A, Mathew N, Lamba W, Rafizadeh R, Chopra N, Dhaliwal A, George TP, Crockford D, Primeau V, Tibbo P, Buckley L, Tanguay R., Can J Psychiatry., 2024
The effects of a provincial opioid prescribing standard on prescribing for pain in adults: an interrupted time‑series analysis
Dimitra Panagiotoglou, Sandra Peterson, M. Ruth Lavergne, Tara Gomes, Rashmi Chadha, Philippa Hawley, Rita McCracken, Canadian Medical Association Journal (CMAJ), 2025
Association between prescribed stimulant medications and overdose among individuals receiving opioid agonist therapy: A retrospective cohort study from British Columbia, Canada
Young S, Fairbairn N, Cui Z, Bach P, Mok WY, Budau J, Slaunwhite A, Ti L, Hayashi K, Nolan S., Addiction. 2025
Evaluation of a hospital-based opioid stewardship program on high-risk opioid prescribing in a Canadian setting: an interrupted time series analysis
Ti L, Mihic T, Beauchesne A, Grant C, Frank I, Haji N, Legal M, Shalansky S, Nolan S., Addict Sci Clin Pract. 2025
Engagement with and acceptability of telephone-based telemedicine in addiction care in Vancouver, Canada, 2020–2023
Hayashi K, Reading D, Bach P, Choi JC, Hedden L, Milloy MJ, DeBeck K, J Addict Med
